X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (46) 46
index medicus (46) 46
oncology (36) 36
male (24) 24
bladder cancer (20) 20
cancer (20) 20
female (19) 19
urology & nephrology (19) 19
aged (18) 18
article (18) 18
middle aged (16) 16
urinary bladder neoplasms - pathology (14) 14
chemotherapy (13) 13
care and treatment (12) 12
metastasis (12) 12
antineoplastic agents - therapeutic use (11) 11
treatment outcome (11) 11
urinary bladder neoplasms - therapy (11) 11
urothelial carcinoma (11) 11
cisplatin (10) 10
immunotherapy (10) 10
urinary bladder neoplasms - drug therapy (10) 10
urology (10) 10
urothelium - pathology (10) 10
neoadjuvant chemotherapy (9) 9
transitional-cell carcinoma (9) 9
clinical trials (8) 8
prostate cancer (8) 8
aged, 80 and over (7) 7
antineoplastic combined chemotherapy protocols - therapeutic use (7) 7
carcinoma, transitional cell - drug therapy (7) 7
expression (7) 7
open-label (7) 7
radical cystectomy (7) 7
research (7) 7
urologic neoplasms - drug therapy (7) 7
bladder-cancer (6) 6
carcinoma (6) 6
risk factors (6) 6
urinary bladder neoplasms - diagnosis (6) 6
usage (6) 6
abridged index medicus (5) 5
adjuvant chemotherapy (5) 5
adult (5) 5
cisplatin-based chemotherapy (5) 5
clinical trials as topic (5) 5
diagnosis (5) 5
drug therapy (5) 5
endothelial growth-factor (5) 5
neoplasm invasiveness (5) 5
neoplasm staging (5) 5
pet (5) 5
phase-ii trial (5) 5
predictive value of tests (5) 5
prospective studies (5) 5
radiology, nuclear medicine & medical imaging (5) 5
solid tumors (5) 5
transitional-cell-carcinoma (5) 5
urologic neoplasms - pathology (5) 5
urothelial cancer (5) 5
animals (4) 4
antibodies, monoclonal - adverse effects (4) 4
bevacizumab (4) 4
bladder (4) 4
cancer therapies (4) 4
ct imaging (4) 4
cystectomy (4) 4
deoxycytidine - administration & dosage (4) 4
deoxycytidine - analogs & derivatives (4) 4
development and progression (4) 4
fluorine radioisotopes (4) 4
gemcitabine plus cisplatin (4) 4
health aspects (4) 4
metastases (4) 4
muscle-invasive bladder cancer (4) 4
neoadjuvant therapy - methods (4) 4
oncology, experimental (4) 4
original reports (4) 4
positron-emission tomography - methods (4) 4
prognosis (4) 4
programmed cell death 1 receptor - antagonists & inhibitors (4) 4
renal-cell carcinoma (4) 4
retrospective studies (4) 4
risk (4) 4
single-arm (4) 4
sodium fluoride (4) 4
survival (4) 4
survival analysis (4) 4
targeted therapy (4) 4
therapy (4) 4
urinary bladder neoplasms - genetics (4) 4
urinary bladder neoplasms - immunology (4) 4
urothelium - drug effects (4) 4
analysis (3) 3
angiogenesis (3) 3
anilides - therapeutic use (3) 3
antibodies, monoclonal - therapeutic use (3) 3
biomarker (3) 3
carcinoma - drug therapy (3) 3
carcinoma, transitional cell - pathology (3) 3
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature Reviews Urology, ISSN 1759-4812, 09/2019
Journal Article
Current Opinion in Oncology, ISSN 1040-8746, 03/2017, Volume 29, Issue 3, pp. 184 - 195
PURPOSE OF REVIEWT-cell checkpoint blockade has become a dynamic immunotherapy for bladder cancer. In 2016, atezolizumab, an immune checkpoint inhibitor,... 
neoantigen | urothelial carcinoma | bladder cancer | mutational burden | immune checkpoint | combination immunotherapy | biomarker | CTLA-4 BLOCKADE | MULTICENTER | BCG | METASTATIC UROTHELIAL CARCINOMA | CISPLATIN PLUS IPILIMUMAB | OPEN-LABEL | ANTI-PD-L1 ANTIBODY | ONCOLOGY | CLINICAL ACTIVITY | EXPRESSION | AVELUMAB MSB0010718C | GENITOURINARY SYSTEM | Edited by Arif Hussain
Journal Article
Current treatment options in oncology, 05/2018, Volume 19, Issue 7, p. 36
Journal Article
Cancer Research, ISSN 0008-5472, 08/2015, Volume 75, Issue 15 Supplement, pp. 140 - 140
Journal Article
The Lancet Oncology, ISSN 1470-2045, 01/2018, Volume 19, Issue 1, pp. 51 - 64
Journal Article
Current Treatment Options in Oncology, ISSN 1527-2729, 7/2018, Volume 19, Issue 7, pp. 1 - 16
Journal Article
The Journal of Nuclear Medicine, ISSN 0161-5505, 12/2008, Volume 49, Issue 12, pp. 2031 - 2041
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 09/2010, Volume 28, Issue 25, pp. 3973 - 3978
Journal Article
The Journal of Urology, ISSN 0022-5347, 05/2018, Volume 199, Issue 5, pp. 1129 - 1142
Although immunotherapy has a long history in the treatment of urothelial carcinoma, its use was limited to intravesical therapy for nonmuscle invasive disease.... 
programmed cell death 1 receptor | urinary bladder neoplasms | carcinoma | immunotherapy | 1ST-LINE TREATMENT | BLADDER-CANCER | METHOTREXATE | OPEN-LABEL | SINGLE-ARM | PEMBROLIZUMAB | THERAPY | CISPLATIN | UROLOGY & NEPHROLOGY | EXPRESSION | ADVERSE EVENTS | Care and treatment | Carcinoma | Cell death | Immunotherapy | Metastasis | Drug therapy | Cancer
Journal Article
Journal of immunology (Baltimore, Md. : 1950), ISSN 0022-1767, 06/2019, Volume 202, Issue 12, pp. 3458 - 3467
Immune checkpoint inhibitors are effective in treating a variety of malignancies, including metastatic bladder cancer. A generally accepted hypothesis suggests... 
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2013, Volume 31, Issue 6, pp. 724 - 730
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2019, Volume 37, Issue 7_suppl, pp. 428 - 428
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2019, Volume 37, Issue 7_suppl, pp. 429 - 429
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.